| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/26/2004 | WO2003033679A3 Methods for predicting transcription levels |
| 02/26/2004 | WO2003031987A3 In vitro model for priocidal activity |
| 02/26/2004 | WO2003030719A3 Methods and kits for use in selecting approaches to treating cancer |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003020899A3 Compositions and methods relating to lung specific genes and proteins |
| 02/26/2004 | WO2003020892A3 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 02/26/2004 | WO2003012137A3 Methods for detecting parkinson's disease |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003004611A3 Human olfactory nucleotide-gated ion channels |
| 02/26/2004 | WO2003002711A3 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 02/26/2004 | WO2003001192A9 Microfabricated separation device employing a virtual wall for interfacing fluids |
| 02/26/2004 | WO2002103058A3 Process for enhanced molecular target detection using layered rolling circle amplification |
| 02/26/2004 | WO2002103050A3 Virus detection method, primers therefor and screening kit |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002101089A3 Method for specific, fast detection of threadlike bacteria |
| 02/26/2004 | WO2002099047A3 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/26/2004 | WO2002088386A3 Nasba-based detection of fungi |
| 02/26/2004 | WO2002087419A3 Biological pacemaker |
| 02/26/2004 | WO2002083937A3 Methods using o6-alkylguanine-dna alkyltransferases |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | WO2002063044A3 Haplotypes of the il15 gene |
| 02/26/2004 | WO2002062204A3 Methods for diagnosing and treating heart disease |
| 02/26/2004 | WO2002061135A3 Dna array sequence selection |
| 02/26/2004 | WO2002061134A3 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 02/26/2004 | WO2002046451A3 Methods for the identification of inhibitors of cysteine syhthase in plants |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2002040708A3 Method for the retention of information data for the application of a biochip/sample support |
| 02/26/2004 | WO2002040542A3 58569 and 50111, human anion exchange proteins and methods of use thereof |
| 02/26/2004 | WO2002039122A3 Methods for the identification and the treatment of cardiovascular disease |
| 02/26/2004 | WO2002038812A3 Method in quantitative analysis of gene and protein expression |
| 02/26/2004 | WO2002038796A3 Methods for determining protease cleavage site motifs |
| 02/26/2004 | WO2002036831A3 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
| 02/26/2004 | WO2002034935A3 In vitro selection of signaling aptamers |
| 02/26/2004 | WO2002031152A3 Intracellular signaling molecules |
| 02/26/2004 | WO2002029005A3 Detection of ras mutations |
| 02/26/2004 | WO2002016643A3 Dna pooling methods for quantitative traits using unrelated populations or sib pairs |
| 02/26/2004 | WO2002002812A3 Method for determining the susceptibility to stoke by analysing the ins gene |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
| 02/26/2004 | US20040039554 Iterative analysis of non-responding population in the design of pharmacogenetic studies |
| 02/26/2004 | US20040039532 Feature quality in array fabrication |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040038925 Inhibition of complement activation and complement modulation by use of modified oligonucleotides |
| 02/26/2004 | US20040038898 Contacting or admixing with the extracorporeal circulating blood with a Factor IXa compound in an amount effective to inhibit thrombosis |
| 02/26/2004 | US20040038896 For diagnosis and therapy |
| 02/26/2004 | US20040038881 For diagnosis, therapy and prophylaxis of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038427 Method for detecting and/or quantifying first molecules |
| 02/26/2004 | US20040038424 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 02/26/2004 | US20040038419 Detecting fluorescence by derivatization of cyanide with fluorescing agent (napthalene-2,3-dialdehyde) via spectrometer; nitrilases; high performance liquid chromatography; high throughput assay |
| 02/26/2004 | US20040038418 For proteins/polypeptides within polyacrylamide matrix; mass spectrometry |
| 02/26/2004 | US20040038417 Method for identifying and/or characterizing a (poly)peptide |
| 02/26/2004 | US20040038406 Nanoparticle delivery systems and methods of use thereof |
| 02/26/2004 | US20040038397 Comprises transfection of neuronal cells with oncogene expression vector; for increased phosphorylation of tau protein |
| 02/26/2004 | US20040038377 Diagnostic test for Alzheimer's disease |
| 02/26/2004 | US20040038375 Method for screening highly active proteases and inhibitors |
| 02/26/2004 | US20040038374 Method for accessing microbial diversity |
| 02/26/2004 | US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038362 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038356 Method and kit for discontinuous density gradient centrifugation to separate a minimum of two substances in a sample; method and kit use is made of colloidal density media and low-density solutions |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038328 Assay for melanogenesis |
| 02/26/2004 | US20040038324 Epothilone resistant cell lines |
| 02/26/2004 | US20040038323 Inhibitors of cell migration and shape changes by inhibiting cortactin and hs-1 medicated actin polymerization |
| 02/26/2004 | US20040038318 Microarray comprised of immobilized monoclonal antibodies for measuring creatine kinase concentration and diagnosing, bone cardiovascular and brain disorders |
| 02/26/2004 | US20040038316 Cell separation device and methods for use |
| 02/26/2004 | US20040038315 Identifying mimetic which potentiates and/or inhibits physiological effects of the ob-protein for treatment of weight, energy balance, hematopoietic and fertility disorders |
| 02/26/2004 | US20040038307 Unique recognition sequences and methods of use thereof in protein analysis |
| 02/26/2004 | US20040038306 Compositions and methods for detection and isolation of phosphorylated molecules |
| 02/26/2004 | US20040038303 Comprises use of small particle with appropriate hydrophilic-lipophilic-balance value to deliver anticarcinogenic agents to cells and/or tissues; drug screening |
| 02/26/2004 | US20040038300 Method for producing and identifying appropriate effectors of target molecules using substance libraries |
| 02/26/2004 | US20040038298 Protein fragment complementation assays for the detection of biological or drug interactions |
| 02/26/2004 | US20040038297 Masp-2,a complement-fixing enzyme, and uses for it |
| 02/26/2004 | US20040038292 Comprises nucleotide sequences which code wound healing proteins for treatment and prevention of scarring, fibrosis, restenosis post angioplasty, psoriasis, benign prostatic hyperplasia, glaucoma and nervous suystem disorders |
| 02/26/2004 | US20040038290 Comprises nucleotide sequences coding heat resistant polymerase for use as DNA replication/amplification tool in genetic engineering |
| 02/26/2004 | US20040038289 Nucleic acid encoding bacillus stearothermophilus delta polymerase subunit |
| 02/26/2004 | US20040038286 Comprises nucleotide sequences coding oxalyl-CoA decarboxylase for diagnosis and treatment of kidney, lipid malabsorptive and inflammatory bowel diseases |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038283 Method of screening for genetic polymorphism |
| 02/26/2004 | US20040038281 Isolated ductal fluid sample |
| 02/26/2004 | US20040038280 Large circular sense molecule array |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038278 Methods and compositions relating to gene silencing |
| 02/26/2004 | US20040038274 Gapped 2' modified oligonucleotides |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040038270 Apparatus for identification and visualization of wastewater bacterium |
| 02/26/2004 | US20040038269 Improving isolation and extraction of nucleic acids from saliva and preservation of nucleotide sequences at room temperature for extended periods of time |
| 02/26/2004 | US20040038268 Support bound probes and methods of analysis using the same |
| 02/26/2004 | US20040038267 Comprises polypeptide associated with signal transduction for diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, nervous system, gastrointestinal, reproductive and developmental disorders |
| 02/26/2004 | US20040038266 Diagnosing hereditary hearing loss in infants via presence or absence of mutation in connexin 26; microarray and high throughput assay |